Daily leukapheresis in healthy family donors after stimulation with rhG-CSF for the treatment of neutropenic patients suffering from severe sepsis

被引：0
|
作者：
Hoecker, P
Worel, N
Peters, C
机构：
[1] Gen Hosp, Vienna, Austria
[2] St Anna Childrens Hosp, A-1090 Vienna, Austria
来源：
TRANSFUSION | 2000年 / 40卷 / 10期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：102S / 102S
页数：1
相关论文
共 28 条
  • [1] Daily leukapheresis in healthy family leukocyte donors following stimulation with rhG-CSF for treatment of neutropenic patients with severe sepsis
    Worel, N
    Witt, V
    Peters, C
    Höcker, P
    BONE MARROW TRANSPLANTATION, 1998, 21 : S194 - S194
  • [2] Leucocyte transfusions from rhG-CSF or prednisolone stimulated donors for treatment of severe infections in immunocompromised neutropenic patients
    Peters, C
    Minkov, M
    Matthes-Martin, S
    Pötschger, U
    Witt, V
    Mann, G
    Höcker, P
    Worel, N
    Stary, J
    Klingebiel, T
    Gadner, H
    BRITISH JOURNAL OF HAEMATOLOGY, 1999, 106 (03) : 689 - 696
  • [3] Leucocyte transfusions from RHG-CSF or prednisolone stimulated donors for treatment of severe infections in immunocompromised neutropenic patients
    Peters, C
    Minkov, M
    Matthes-Martin, S
    Pötschger, U
    Witt, V
    Mann, G
    Höcker, P
    Worel, N
    Stary, J
    Klingebiel, T
    Gadner, H
    BONE MARROW TRANSPLANTATION, 2001, 27 : S46 - S46
  • [4] PBSC COLLECTION IN HEALTHY DONORS AFTER MOBILIZATION WITH RHG-CSF
    SCIME, R
    MAJOLINO, I
    VASTA, S
    BUSCEMI, F
    INDOVINA, A
    FIANDACA, T
    PAMPINELLA, M
    CATANIA, P
    CAVALLARO, AM
    CARONIA, G
    SANTORO, A
    EXPERIMENTAL HEMATOLOGY, 1995, 23 (08) : 756 - 756
  • [5] Granulocyte transfusions for treatment of severe infections - Leukocyte transfusions from rhG-CSF or prednisolone stimulated donors for treatment of severe infections in immunocompromised neutropenic patients
    Peters, C
    BONE MARROW TRANSPLANTATION, 2002, 30 : S39 - S40
  • [6] A randomized comparison of once versus twice daily rhG-CSF (filgrastim) for stem cell mobilisation in healthy donors for allogeneic transplantation.
    Kroeger, N
    Renges, H
    Krueger, W
    Gutensohn, K
    Loeliger, C
    Carrero, I
    Cortes, L
    Zander, AR
    BLOOD, 2000, 96 (11) : 518A - 518A
  • [7] Safety of a low dosage filgrastim (rhG-CSF) treatment in non neutropenic surgical intensive care patients with an inflammatory process
    GrossWeege, W
    Weiss, M
    Schneider, M
    Wenning, M
    Harms, B
    Dumon, K
    Ohmann, C
    Roher, HD
    INTENSIVE CARE MEDICINE, 1997, 23 (01) : 16 - 22
  • [8] CIRCULATING ENDOTHELIAL PROGENITOR CELLS (CEPCS) AFTER RECOMBINANT HUMAN GRANULOCYTE-COLONY STIMULATING FACTOR (RHG-CSF) IN HEALTHY DONORS
    Topcuoglu, P.
    Karacaoglu, O.
    Sahin, S.
    Topcuoglu, P.
    Dalva, K.
    Arslan, O.
    VOX SANGUINIS, 2010, 99 : 504 - 505
  • [9] Biological effects of flt3-L on peripheral blood progenitors obtained from cancer patients or healthy donors mobilised with chemotherapy or rhG-CSF
    Aurran-Schleinitz, T
    Humeau, L
    Bardin, F
    Imbert, AM
    Charbord, P
    Chabannon, C
    BRITISH JOURNAL OF HAEMATOLOGY, 1998, 102 (01) : 22 - 22
  • [10] Safety of a low-dosage Filgrastim (rhG-CSF) treatment in non-neutropenic surgical intensive care patients with an inflammatory process
    W. Gross-Weege
    M. Weiss
    M. Schneider
    M. Wenning
    B. Harms
    K. Dumon
    C. Ohmann
    H.-D. Röher
    Intensive Care Medicine, 1997, 23 : 16 - 22
123